Navigation Links
NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
Date:10/27/2008

Data presented at annual ICAAC/IDSA meeting in Washington, D.C.

WASHINGTON, Oct. 27 /PRNewswire/ -- A novel topical therapy for nail fungus, NB-002, has demonstrated a new topical approach to healing nail fungus by penetrating skin pores and diffusing through the skin that surrounds the entire nail plate, according to a study conducted by NanoBio Corporation.

The data represent a unique approach to treating nail fungus (onychomycosis), which resists topical therapies because they cannot penetrate the nail and access the site of infection. The results were reported this morning at the 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting in Washington, D.C.

"In testing NB-002 on human cadaver skin, we have demonstrated that the lotion permeates and then laterally diffuses across tissue plains in the epidermis and the dermis to more than 1 centimeter away from the site of application," said Susan Ciotti, Ph.D., director of formulations and research and development, and presenting author of the data.

"The average great toenail measures 22 millimeters across, so we are able to deliver NB-002 across the entire span of an infected human large toenail, a huge advance in the treatment of onychomycosis," Ciotti said.

Because of its novel mode of penetration and diffusion, NB-002 is able to achieve 50 times the minimum drug concentration required to kill the fungus in the very center of the nail bed. Only 4 micrograms per gram of tissue are required for NB-002 to kill fungal infections.

Newer, more effective therapies for nail fungus are important because onychomycosis remains a large unmet medical need, according to the NanoBio scientists. Oral systemic medications are plagued by serious hepatic and cardiac toxicity concerns, while current topical medications are not effective because they are unable to penetrate to the site of i
'/>"/>

SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis
2. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
3. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
4. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
5. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
6. HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
7. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
8. MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy
9. Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus
10. 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
11. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Ill. , May 4, 2015 RadiologyAuction will ... with live video and product demonstrations at the end ... imaging equipment such as Kodak and Fuji Cr,s, Agfa ... auctioned at the first event. Various imaging equipment will ... www.RadiologyAuction.com . After years of buying and ...
(Date:5/4/2015)... , May 4, 2015 PharmaEngine, Inc. ... Pharmaceuticals, Inc. (NASDAQ: MACK ) with its ... ) jointly announced that Baxter has submitted a ... Agency (EMA) for MM-398 (irinotecan liposome injection), also ... of the pancreas who have been previously treated ...
(Date:5/4/2015)... Pa. , May 4, 2015  Makindus, Inc. ... today that the European Medicines Agency (EMA) has granted ... the treatment of Stargardt,s Disease. "We are ... MI-100 to treat Stargardt,s disease in place for ... development program in the United States ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2
... , WALTHAM, Mass., Nov. 17 Decision Resources, one ... and healthcare issues, finds that sales of agents to treat ... decade, increasing from $360 million in 2008 to $450 million ... the United Kingdom and Japan. , The new Pharmacor report ...
... 16 Symmetry Medical Inc. (NYSE: SMA ), a ... and other medical markets, announced today that Brian S. Moore, President ... and Chief Financial Officer, are scheduled to present at the 21st ... New York City on Tuesday, December 1, 2009 at 12:30 p.m. ...
Cached Medicine Technology:Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing From $360 Million in 2008 to $450 Million in 2018 2Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference 2
(Date:5/4/2015)... (PRWEB) May 04, 2015 Malibu ... oral antiseptic breath spray. KissSafe™ is the first ... a safer experience while adding fresh breath appeal. ... and effectively kills germs in the mouth and ... also contains ingredients that possess additional wellness benefits. ...
(Date:5/4/2015)... Milton Hershey School® has named J. Anthony Graves, ... recognizing his commitment to pediatric cancer research and the ... students. , “Dr. Graves is a tremendous example of ... a top-notch education, a nurturing environment, and the opportunity ... ’85, president of MHS. “He is applying the values ...
(Date:5/4/2015)... Johnson & Wales University (JWU) held a groundbreaking ceremony ... on Wednesday, April 22. , Johnson & Wales becomes the ... the re-alignment of Interstate-195. JWU’s new academic building, which will ... in Providence, is scheduled to be completed in July 2016. ... university purchased in 2012. , “It has long been our ...
(Date:5/4/2015)... The opportunity for children to dream of a ... forces behind The Fairy Godmother Next Door, a new children’s ... Stark. , The inspiration for the enchanting story of a ... Stark’s desire to be a fairy godmother. , “My wish ... my neighbors’ children since they were born. We discuss fairies ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Now in ... IPC clinical leaders who have made outstanding contributions to ... they serve, both in acute and post-acute care settings. ... Year, Post-Acute Provider of the Year, Advanced Practice Clinician ... Specialist Provider of the Year. Recipients are selected by ...
Breaking Medicine News(10 mins):Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3
... NEW YORK, June 25 International superstar Beyonce will perform ... to benefit the Charles & Phyllis Newman Foundation and the ... the most widely recognized and highly respected women in pop ... album I Am . . . Sasha Fierce ...
... , , Company,s Behavioral Health Grants Now ... ValueOptions(R), Inc., of Norfolk, Virginia, the behavioral health organization ... Mexico since 2005, announced today that it is awarding $3.1 ... services across the state. , , (Logo: ...
... ... Institute (SSI) announces the launch of the National ObamaCare Opt Out (NOOO!) ... not force them to join a national healthcare system, nor to purchase ... http://www.patientoptout.com , is modeled after the National Do Not Call Registry, and ...
... ... Children with Muscular Dystrophy , ... Boston, MA (PRWEB) June 25, 2009 -- In immediate response to the Muscular Dystrophy Association,s ... virus, more commonly known as the "swine flu" Camp Promise, today announced its efforts to ...
... 25 According to Millennium Research Group (MRG), ... pharmacomechanical thrombectomy (PMT) procedure adoption will accelerate over ... interest in treating deep vein thrombosis (DVT). Although ... Adjunctive Catheter-Directed Thrombolysis) trial, which will compare catheter-directed ...
... Prompts Addition of Veteran Sales Executives to Premium Provider of ... June 25 MedPro Imaging, a premium provider of new ... sales executives in support of ongoing growth. MedPro, which recently ... quarter of 2009, has named Scott Wayman the zone manager ...
Cached Medicine News:Health News:ValueOptions(R) Reinvests $3.1 Million in New Mexico 2Health News:Social Security Institute Launches the National Obamacare Opt Out (NOOO!) Registry 2Health News:Social Security Institute Launches the National Obamacare Opt Out (NOOO!) Registry 3Health News:Camp Promise Rallies To Provide Massachusetts Children With Alternative To MDA Canceled Summer Camp 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 3Health News:MedPro Imaging Adds Wayman and Sanford to Growing Sales Team 2Health News:MedPro Imaging Adds Wayman and Sanford to Growing Sales Team 3
Half aprons used to protect pelvic regions...
Light and comfortable thyroid protection. The softest, most comfortable throid collar made. No neck irritating binding....
... full protection is necessary, the Two-Piece ... add to your comfort through more ... greater flexibility. The vest comes with ... hanging loops as well as an ...
... Apron has standard front protection. ... from the shoulders to the ... a 6" wide elastic belt. ... fit various sized individuals. Available ...
Medicine Products: